An irreversible DPD inhibitor
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
Eniluracil is an irreversible inhibitor of dihydropyrimidine dehydrogenase (DPD; Ki = 1.6 ?M), the rate-determining enzyme in the catabolism of pyrimidines, including 5-fluorouracil .1,2 It inhibits liver DPD and elevates plasma pyrimidine levels in rats (ED50s = 1.8 and 10 ?g/kg, respectively).2 Eniluracil (2 mg/kg) potentiates the antitumor effects of 5-fluorouracil in MC-38 murine colon carcinoma and MOPC 315 murine myeloma models.
1.Porter, D.J., Chestnut, W.G., Merrill, B.M., et al.Mechanism-based inactivation of dihydropyrimidine dehydrogenase by 5-ethynyluracilJ. Biol. Chem.267(8)5236-5242(1992) 2.Baccanari, D.P., Davis, S.T., Knick, V.C., et al.5-Ethynyluracil (776C85): A potent modulator of the pharmacokinetics and antitumor efficacy of 5-fluorouracilProc. Natl. Acad. Sci. USA90(23)11064-11068(1993)
LX1606 Hippurate (Telotristat etiprate)
¥580.00 ¥725.00
没有评价数据